Dr Reddys Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	500124	NSE Symbol:	DRREDDY	P/E :	21.9
ISIN Demat:	INE089A01031	Div & Yield %:	0.66	EPS :	55.59
Book Value:	377.55	Market Cap (Rs. Cr.):	101,627.83	Face Value :	1

Date	Headline
24-Mar-26	Dr Reddys Laboratories schedules board meeting
21-Mar-26	Dr. Reddy's launches injectable semaglutide under the brand name Obeda®
12-Mar-26	Dr Reddys Laboratories allots 10,275 equity shares under ESOP
14-Jan-26	Dr. Reddy's launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%
24-Dec-25	Dr Reddys Laboratories to announce Quarterly Result
09-Dec-25	Dr Reddys Laboratories allots 9,165 equity shares under ESOS
24-Nov-25	Dr. Reddy's receives EC marketing authorization for AVT03 (denosumab)
13-Nov-25	Dr Reddys Laboratories allots 7,430 equity shares under ESOS
10-Nov-25	Dr Reddys announces change in senior management
23-Sep-25	Dr Reddys Laboratories schedules board meeting

Company Snapshot